Free Newsletter
Pharma's new aims explain reform support
Why is Big Pharma such a willing supporter of healthcare reform? The industry has transformed from a business aiming to sell pills to the masses to one that markets very expensive treatments to small groups of sick people--and that changes everything, Forbes' Matthew Herper contends. Report
More stories about healthcare reform
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: